No Data
H.C. Wainwright Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $25
H.C. Wainwright analyst Patrick Trucchio maintains $uniQure NV(QURE.US)$ with a buy rating, and maintains the target price at $25.According to TipRanks data, the analyst has a success rate of 29.0%
HC Wainwright & Co. Reiterates Buy on UniQure, Maintains $25 Price Target
UniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease
UniQure N.V. (NASDAQ:QURE) Analysts Are Cutting Their Estimates: Here's What You Need To Know
UniQure to Cut 65% of Workforce, or 300 Jobs, in Major Restructuring
Goldman Sachs Maintains Neutral on UniQure, Raises Price Target to $10